Sekkei Bio
Computational and RNA-based drug and vaccine design
Sekkei Bio
About
Sekkei Bio is a biopharmaceutical startup that combines deep science, physics and machine learning on a proprietary computational platform to design multi-targeted drugs and RNA therapeutics, with programmes spanning oral and thermostable insulin and non-opioid analgesics.
Startup Information
Company Name
Sekkei Bio Private Limited
Location
Chennai
Incubated Year
2017
Incubated With
IITM Bioincubator
Sector
Healthcare & Biotech
Website
Focus Areas
Founder Details
Founder
Anand Khedkar
Designation
Co-founder
Bio
Co-founder at Sekkei Bio, contributing to the company's computational drug-design and biopharmaceutical development programmes.
Founder
Anirudh Ranganathan
Designation
Co-founder
Bio
Co-founder at Sekkei Bio, working on the company's RNA-therapeutics and computational drug-discovery platform.
Founder
Monalisa Chatterji
Designation
Co-founder
Bio
Co-founder at Sekkei Bio, contributing to the company's drug and vaccine development programmes targeting global unmet health needs.